President Trump nominates Kevin Warsh, a former Fed governor with Wall Street ties, to succeed Jerome Powell as Federal Reserve Chair. His confirmation faces scrutiny amid questions over monetary policy direction and the central bank's political independence.
With Bitcoin consolidating below $90,000, a significant retreat from its October highs, investors are weighing whether this is a strategic entry point or a warning sign. We examine the competing narratives shaping the market's next move.
Elon Musk is reportedly in discussions to merge his aerospace giant SpaceX with his artificial intelligence venture xAI, aiming to create an integrated powerhouse for deploying AI data centers in orbit, powered by space solar energy.
An unexpected jump in the Producer Price Index for December underscores the stubborn nature of inflation, with rising wholesale costs threatening to ripple through the economy and sustain higher prices for households.
Congress has approved $23 billion in initial funding for the ambitious Golden Dome missile defense initiative, yet the absence of a detailed spending blueprint from the Pentagon is stalling progress and clouding investment prospects for 2026.
Pharmaceutical leader Eli Lilly will build a new manufacturing facility in Lehigh County, marking the largest life sciences investment in Pennsylvania history and bolstering U.S. production of next-generation weight-loss drugs.
From post-IPO darling to a stock trading near historic lows, Rivian faces a critical five-year window. With new models on the horizon and a major Volkswagen partnership, analysts see a path to growth—if it can navigate fierce competition and persistent losses.
St. Louis Fed President Alberto Musalem argues the current interest rate stance is appropriate, signaling a pause in the central bank's easing cycle unless the labor market weakens or inflation drops unexpectedly.
While retirement planning often focuses on savings, a critical financial metric—net worth—reveals a more precarious reality for many households. We examine the causes and consequences of negative net worth, offering actionable steps to build a stronger financial foundation.
President Trump's nomination of Kevin Warsh, a known monetary policy hawk, to lead the Federal Reserve sent initial shockwaves through equities and bonds on Friday, raising questions about the future path of interest rates.
Mosaic Company's shares have surged over 16% in the past month, reigniting debate among investors. A deep dive into valuation metrics reveals a stark contradiction: while a discounted cash flow model flags the stock as overvalued, its rock-bottom P/E ratio suggests significant upside potential. We break down the numbers and what they mean for long-term investors.
American Express reported fourth-quarter earnings that narrowly missed analyst forecasts, yet a modest stock decline reflects investor confidence in its robust guidance and the sustained momentum of its high-end cardmember base.
Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.
Despite lagging the broader market over the past year, Ingersoll Rand shows signs of a strategic pivot. Wall Street sees modest upside potential as the industrial giant navigates headwinds and pursues growth through acquisition.
BlackRock has increased its stake in the diversified precious metals miner Sibanye-Stillwater beyond 5%, signaling strong institutional confidence amid a historic rally in gold and platinum group metals. We examine the drivers behind the surge and what it means for investors.
A Boston federal judge has temporarily blocked the Biden administration's move to terminate Temporary Protected Status for over 5,000 Ethiopians, granting more time for a legal challenge against the decision.
Popular, Inc. (BPOP) shares have rallied following robust 2025 results, driven by higher net interest income, EPS growth, and aggressive shareholder returns via dividends and buybacks. With the stock up nearly 20% in 90 days, investors are weighing whether its current valuation still offers an entry point.
French biopharma firm Inventiva (ENXTPA:IVA) has delivered a stunning 126% total return to shareholders over the past year, sharply contrasting with losses over a three-year horizon. As the stock experiences short-term pullbacks, analysts debate whether its current €5.23 price reflects future promise or present hype, with a key drug candidate hanging in the balance.
Twilio shares have faced significant pressure, dropping over 14% in the past month. As the cloud communications leader grapples with investor skepticism, analysts are divided on whether the sell-off presents a value entry point or reflects justified concerns about competition and margins.
A significant stock sale by AutoZone's Senior Vice President Richard Craig Smith has prompted investors to re-examine the automotive retailer's valuation metrics and leverage position, amid a shifting landscape for the auto aftermarket industry.
